Galena Biopharma Inc
Change company Symbol lookup
Select an option...
GALE Galena Biopharma Inc
GME GameStop Corp
KMI+ Kinder Morgan Inc *W EXP 05/25/2017
MLR Miller Industries Inc
HPT Hospitality Properties Trust
NFBK Northfield Bancorp Inc
BAESF BAE Systems PLC
LLNW Limelight Networks Inc
GPS Gap Inc
FCX Freeport-McMoRan Inc
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system to seek out and attack any residual cancer cells.

Closing Price
$1.43
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
24,350
  • Prev Close
    1.43
  • Today's Open
    0.00
  • Day's Range
    --
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    12:00a ET 04/28/16
  • Last (size)
    0
  • 52-Wk Range
    0.5855 - 2.39
    LowHigh
  • (06/08/15 - 02/03/16)
    144.24%
  • 80.2%
  • Market Cap
    259.9M
  • Shares Outstanding
    181.7M
  • -0.24
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.7
  • 14.49
  • (% of float 04/15/16)
    12.76

Latest News

April 27, 2016
7:05 am ET
Globe Newswire
April 26, 2016
7:05 am ET
Globe Newswire
April 19, 2016
9:05 am ET
Globe Newswire
April 18, 2016
8:01 am ET
Market Wire
April 14, 2016
2:00 am ET
PR Newswire
March 30, 2016
7:15 am ET
Zacks
March 29, 2016
7:05 am ET
Globe Newswire
March 11, 2016
1:56 pm ET
Globe Newswire
March 10, 2016
4:10 pm ET
Globe Newswire
10:57 am ET
Zacks
March 07, 2016
7:05 am ET
Globe Newswire
March 02, 2016
9:00 pm ET
PR Newswire
February 26, 2016
7:05 am ET
Globe Newswire
February 16, 2016
5:00 pm ET
Globe Newswire
February 08, 2016
7:05 am ET
Globe Newswire
February 02, 2016
7:05 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.